Live Breaking News & Updates on Rezolute Inc

Stay updated with breaking news from Rezolute inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Rezolute, Inc. (NASDAQ:RZLT) Sees Large Increase in Short Interest

Rezolute, Inc. (NASDAQ:RZLT – Get Free Report) was the recipient of a large growth in short interest during the month of May. As of May 31st, there was short interest totalling 814,600 shares, a growth of 162.0% from the May 15th total of 310,900 shares. Based on an average daily trading volume, of 571,100 shares, […] ....

United States , Daron Evans , Craig Hallum , Rosalind Advisors Inc , Vanguard Group Inc , Virtu Financial , Acadian Asset Management , Affinity Asset Advisors , Securities Exchange Commission , Rezolute Inc , Maxim Group , Get Free Report , Exchange Commission , Asset Advisors , Asset Management , Rosalind Advisors , Trading Down , Rezolute Daily ,

Rezolute, Inc. (NASDAQ:RZLT) Insider Brian Kenneth Roberts Purchases 7,500 Shares

Rezolute, Inc. (NASDAQ:RZLT – Get Free Report) insider Brian Kenneth Roberts bought 7,500 shares of the company’s stock in a transaction on Thursday, May 23rd. The stock was bought at an average cost of $2.69 per share, with a total value of $20,175.00. Following the completion of the purchase, the insider now owns 50,052 shares […] ....

United States , Brian Kenneth Roberts , Maxim Group , Rezolute Inc , Acadian Asset Management , Vanguard Group Inc , Affinity Asset Advisors , Rosalind Advisors Inc , Virtu Financial , Get Free Report , Kenneth Roberts , Asset Management , Rezolute Daily ,

Rezolute Reports Positive Topline Results from Phase 2 Proof of Concept Study of RZ402 in Patients with Diabetic Macular Edema (DME) - Rezolute (NASDAQ:RZLT)

Met primary study endpoints: good safety profile and reduction in central subfield thickness (CST) First oral therapy to demonstrate reduction in macular edema; supports potential for early disease intervention Virtual ....

Tirtht Patel , Christen Baglaneas , Araj Agrawal , Arshad Khanani , Quan Dong Nguyen , Stanford University School Of Medicine , Head Of Ophthalmological Clinical Development At Rezolute , Rezolute Inc , Securities Exchange , Reno School Of Medicine , Byers Eye Institute , University Of Nevada , Stanford University School , Scientific Advisory , Clinical Professor , Reno School , Primary Investigator , Vice President , Ophthalmological Clinical Development , Corrected Visual Acuity , Early Treatment Diabetic Retinopathy Study , Diabetic Retinopathy Severity Score , Study Eye , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act ,

Rezolute Reports Positive Topline Results from Phase 2 Proof of Concept Study of RZ402 in Patients with Diabetic Macular Edema (DME)

Met primary study endpoints: good safety profile and reduction in central subfield thickness First oral therapy to demonstrate reduction in macular edema; supports potential for early disease. ....

Christen Baglaneas , Quan Dong Nguyen , Araj Agrawal , Arshad Khanani , Tirtht Patel , Reno School Of Medicine , Securities Exchange , University Of Nevada , Rezolute Inc , Stanford University School Of Medicine , Head Of Ophthalmological Clinical Development At Rezolute , Byers Eye Institute , Stanford University School , Scientific Advisory , Clinical Professor , Reno School , Primary Investigator , Vice President , Ophthalmological Clinical Development , Corrected Visual Acuity , Early Treatment Diabetic Retinopathy Study , Diabetic Retinopathy Severity Score , Study Eye , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act ,

Rezolute Inc. (RZLT) Reports Positive Topline Results from Phase 2 Proof of Concept Study of RZ402

Rezolute Inc. (RZLT) Reports Positive Topline Results from Phase 2 Proof of Concept Study of RZ402
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Araj Agrawal , Quan Dong Nguyen , Arshad Khanani , Christen Baglaneas , Tirtht Patel , Stanford University School Of Medicine , Byers Eye Institute , University Of Nevada , Securities Exchange , Rezolute Inc , Reno School Of Medicine , Head Of Ophthalmological Clinical Development At Rezolute , Stanford University School , Scientific Advisory , Clinical Professor , Reno School , Primary Investigator , Vice President , Ophthalmological Clinical Development , Corrected Visual Acuity , Early Treatment Diabetic Retinopathy Study , Diabetic Retinopathy Severity Score , Study Eye , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act ,